PGNY

PGNY

USD

Progyny Inc. Common Stock

$23.230+0.210 (0.912%)

Preço em tempo real

Healthcare
Healthcare Plans
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$23.020

Máximo

$23.375

Mínimo

$22.860

Volume

0.10M

Fundamentos da empresa

Capitalização de mercado

2.0B

Setor

Healthcare Plans

País

United States

Estatísticas de negociação

Volume médio

1.58M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $13.39Atual $23.230Máximo $33.84

Relatório de análise de IA

Última atualização: 3/05/2025
Gerado por IAFonte de dados: Yahoo Finance, Bloomberg, SEC

PGNY: Progyny Inc. Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: PGNY Generate Date: 2025-05-03 11:22:13

Let's break down what's been happening with Progyny stock lately. We'll look at the latest news, check out how the price has been moving, and see what some prediction models are saying.

Recent News Buzz

What's been hitting the news wires lately? Well, it looks pretty good on the surface.

First off, the company just announced when they'll report their financial results for the first quarter of 2025. That's set for after the market closes on April 24th. Earnings reports are always a big deal; they give us a real look under the hood at how the business is doing. Investors will be watching this closely to see if the company is meeting expectations.

Even more recently, Progyny brought in some new talent at the top. They named a Chief Operating Officer (COO) and a Chief Product Officer (CPO). These are key roles, especially for a company in the healthcare and family building space. Bringing in experienced folks for these positions usually signals that the company is focused on improving operations and developing its offerings. That's generally seen as a positive step.

So, the news vibe is leaning positive, mainly thanks to strengthening the leadership team, though the upcoming earnings report is the next big event everyone's waiting for.

Checking the Price Action

Looking at the stock's moves over the past month or so, it's been a bit of a ride, but it seems to have settled into a range. Back in early February, the price was hanging around the low $20s. There was a noticeable jump towards the end of February, hitting over $26 briefly, but it quickly pulled back.

Since that spike and correction, the price has mostly traded between roughly $21 and $23. The last few days show the stock closing around the $23.23 mark (as of May 2nd). It's been relatively stable in this area recently, maybe showing a slight upward nudge in the last couple of trading sessions.

Now, let's peek at the AI's crystal ball. The prediction model suggests some positive movement ahead. It's forecasting small gains for today and tomorrow (around 0.83% and 0.29%), but then a more significant jump (3.30%) the day after tomorrow. The AI seems to think there's some room for the price to climb from here.

Putting It All Together: Outlook & Ideas

So, putting all this together, what's the picture?

The positive news about new leadership, combined with the AI model predicting upward movement, especially a notable jump in a couple of days, seems to give the stock a potentially positive near-term leaning. The recent price action has been stable, which could be seen as consolidating before a potential move.

However, it's not all clear skies. Some technical indicators are flashing caution signs, like the DMI suggesting a bearish trend and a MACD "death cross." Also, some fundamental points like lower-than-expected revenue growth and high debt are worth keeping in mind for the longer view.

Given the AI's forecast and the positive news sentiment, one possible strategy might involve looking at the stock around its current price level. The AI prediction and some analysis point to potential entry points around $23.25 to $23.37. The May 2nd close was right there at $23.23, so the current area looks interesting if you're considering a move based on this data.

If you decide to jump in, thinking about risk is crucial. A potential level to consider taking profits, based on the analysis, could be around $23.68. On the flip side, to protect yourself if the price goes the wrong way, a stop-loss order around $20.90 might make sense. That level is below some recent lows and could help limit potential losses if the positive predictions don't pan out or the technical/fundamental concerns weigh heavier.

Company Context

Remember, Progyny is in the Healthcare Plans sector, specifically focusing on women's health and family building benefits. The news about bringing in a COO and CPO makes sense in this context – they're likely aiming to improve how they deliver those services and develop new ones. The upcoming earnings report will be key to seeing if their business performance matches the positive operational news.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Notícias relacionadas

GlobeNewswire

Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building, will report its financial results for the quarterly period ended March 31, 2025, after

Ver mais
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
GlobeNewswire

Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Progyny (NASDAQ:PGNY), a global leader in women's health and family building, today announced the appointments of Melissa Cummings as the company's first Chief Operating

Ver mais
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer

Previsão de IABeta

Recomendação de IA

Altista

Atualizado em: 4/05/2025, 00:39

BaixistaNeutroAltista

63.3% Confiança

Risco e negociação

Nível de risco3/5
Risco médio
Adequado para
Moderado
Guia de negociação

Ponto de entrada

$23.25

Tomar lucro

$23.68

Parar perda

$20.90

Fatores-chave

DMI mostra tendência de baixa (ADX:13.0, +DI:6.8, -DI:8.0), sugerindo cautela
O preço atual está extremamente próximo do nível de suporte ($23.22), sugerindo forte oportunidade de compra
O volume de negociação é 4.0x a média (12,349), indicando pressão de compra extremamente forte
MACD -0.0088 está abaixo da linha de sinal -0.0004, indicando um crossover de baixa

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.